MentionFox
Home › Who owns › Aktis Oncology, Inc.
Owners, funding and legal record

Who owns Aktis Oncology, Inc.? Owners, funding and legal record

The most recent 5%+ ownership report on Aktis Oncology, Inc. names Blue Owl Capital Holdings LP holding 5.92% (Schedule 13G, filed 2026-05-14).

About to sign with, pay or invest in Aktis Oncology, Inc.? See the free Snapshot first.

Free to see. No signup.

Before you sign or pay

Who is behind it

Aktis Oncology, Inc.: incorporated in Delaware; business address in Boston, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G, 2026-05-14).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G, 2026-05-14Blue Owl Capital Holdings LP5.92%
Schedule 13D, 2026-01-20Ecor1 Capital, LLC9.1%
Schedule 13D, 2026-01-20Mpm Bioventures 2018, L.P.19.3%
Schedule 13D, 2026-01-15Eli Lilly And Company11.9%
Schedule 13D, 2026-01-14Vv Manager Ii LLC10.9%
FiledPersonRoleChangeEffective
Form 8-K, 2026-04-16Glenn GormleyDirectorappointed

Money raised

FiledSoldOffered
Form D, 2024-10-02$175M$175M

Latest IPO step: Aktis Oncology, Inc. filed its final IPO prospectus, ticker AKTS (424B4, 2026-01-09).

IPO filings: 424B4, 2026-01-09, S-1/A, 2026-01-07, S-1/A, 2026-01-05, S-1, 2025-12-19; ticker AKTS on Nasdaq Global Select Market.

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/aktis-oncology
Last updated 2026-10-18
Who owns Aktis Oncology, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/aktis-oncology